GreenfieldAnalysis

Stay out when Line L is broken to protect your portfolio!

NASDAQ:ADMA   ADMA Biologics Inc
Stay out when Line L is broken to protect your portfolio!

What is Line L? Line L is a horizontal line that connects the security lowest price reached previously and later retested and penetrated.

Never average into a stock when you see Line L is broken. If you average into a stock when the price plunge after Line L is broken you will amplify your losses significantly. Let me give you an example. With the weekly chart of ADMA, you can see Line L is broken on Feb 23, 2015, followed by -$2.35 drop that is -23.94% of your portfolio. This happened again on Dec 28, 2015, followed by -$3.66 drop that is -46.50% of your portfolio. Again, this happened on May 8, 2017, followed by -$2.00 drop that is -48.16% of your portfolio. This pattern repeated on Dec 10, 2018, followed by -$2.48 that is -54.94% of your portfolio. Lastly, on Feb 3, 2020, Line L is broken followed by -$1.46 that is -$43.18%. Currently, Line L is at around $1.75, if Line L is broken again at $1.75 then there is a high probability the stock may be more bearish once the price breakout of this descending triangle pattern.

I used the market probe price level to determine the price for my Line L. A market probe is a way for the bulls and bears to measure the market desire to advance further in the current trend direction or not. For an explanation of a market probe, please read my article on December 12, 2020, with the title, "A Market Probe versus A Shadow."

Thank you for reading! Please click Like and click Follow to see more articles and examples.

Greenfield


Disclosure: Just a market opinion by Greenfield Analysis LLC for educational purposes. This is not a recommendation. Greenfield Analysis LLC has no investment in any of the securities mentioned in the article, and no plan to initiate a trade in any of the securities mentioned. Investment involves substantial risk. You should consider carefully before making an investment. Investment at your own risk.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.